Doctors, scientists and epidemiologists have made strides in their research to learn what they can about SARS-CoV-2 and the illness it causes, COVID-19.
Multiple vaccines are in different stages of development as institutions scrutinize the effectiveness of existing drugs to treat coronavirus patients in clinical trials. Social distancing restrictions and lockdown measures have flattened the curve in parts of the country, and states have begun reopening in phases.
These are the top 10 questions we hope to have answers to in the next 100 days.
But experts say that there's more to learn about the virus, and as the United States surpasses 100,000 deaths, many wonder if that learning curve is just too steep. Let’s take a moment to honor the lives of those we have lost, and begin to comprehend the wound they leave behind.